<DOC>
	<DOCNO>NCT01078584</DOCNO>
	<brief_summary>The in-MAU-tion study conduct determine percentage hypertensive participant without diabetes reach CHEP ( Canadian Hypertension Education Program ) define blood pressure target . Additionally , study ass change renal function ( microalbuminuria , estimate glomerular filtration rate ) hypertensive participant treat trandolapril ( Mavik® ) examine patient satisfaction trandolapril ( Mavik® ) therapy .</brief_summary>
	<brief_title>Canadian Study Trandolapril Blood Pressure Hypertensive Patients</brief_title>
	<detailed_description>There interventional implication study . The study run consideration Canadian Hypertension Education Program guideline per standard practice care . Data collection record appropriate case report form . The data collect consist : patient demographic ( gender , race , age , weight ) , blood pressure reading , heart rate , coexist comorbidities , concomitant chronic medication ( generic name dosage ) , indication dose trandolapril ( Mavik® ) patient compliance . Laboratory value ( microalbuminuria , estimate glomerular filtration rate ) collect data available patient . For baseline value ( study Day 0 ) , laboratory value record within past year prior baseline visit ( Visit 1 ) record , value available . As per Canadian Hypertension Education Program recommendation support educational measure , patient provide ( 1 ) educational tool ( nutrition guidebook ) ( 2 ) home blood pressure monitoring device . As per research development guideline , blood pressure device retrieve end study . Approximately 8,000 hypertensive participant enrol study 700 site across Canada . Sample size estimation base assumption 67.2 % non-diabetic hypertensive participant ( assume make 69 % eligible participant population ) would reach blood pressure target &lt; 140/90mm Hg , 22 % diabetes participant ( 31 % eligible population ) would meet blood pressure target &lt; 130/80 mm Hg trandolapril ( Mavik® ) therapy .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Trandolapril</mesh_term>
	<criteria>Adults capable provide consent uncontrolled hypertension Participants either treatmentnaïve uncontrolled hypertension exist antihypertensive medication . Participants exclude participation study take trandolapril ( Mavik® ) , alone combination , 1 month prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Uncontrolled hypertension</keyword>
	<keyword>trandolapril</keyword>
</DOC>